Simultaneous determination of moxifloxacin and H2 receptor antagonist in pharmaceutical dosage formulations by RP-HPLC: Application to in vitro drug interactions

Quimica Nova

Volumn 34, Issue 4, 2011, Pages 683-688

  Sultana, Najma ^a   Akhtar, Mahwish ^a   Shamim, Sana ^a   Gul, Somia ^a   Arayne, Muhammad Saeed ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

ANOVA; H2 receptor antagonists; Moxifloxacin

Indexed keywords

EID: 79957873771     PISSN: 01004042     EISSN: 16787064     Source Type: Journal    
DOI: 10.1590/S0100-40422011000400022     Document Type: Article

References (31)

1. Andriole, V. T.; Formulary 2002, 37, 13.
2. Appelbaum, P. C.; Hunter, P. A.; Int. J. Antimicrob. Agents 2002, 16, 5.
3. The Merck Index 2001, p. 1125.
4. Trindade, M. A. G.; Cunha, P. A. C.; de Araújo, T. A.; da Silva, G. M.; Ferreira, V. S.; Ecl. Quím. 2006, 31, 31.
5. Sullivan, J. T.; Woodruff, M.; Lettieri, J.; Agarwal, V.; Krol, G. J.; Leese, P.T.; Watson S.; Heller, A. H.; Antimicrob. Agents Chemother. 1999, 43, 2793.
6. De Almeida, M. V.; Saraiva, M. F.; de Souza, M. V. N.; da Costa, C. F.; Vicente, F. R. C.; Lourenco, M. C. S.; Bioorg. Med. Chem. Lett. 2007, 17, 5661.
7. O'Connor, K. A.; O'Mahony, D.; Eur. J. Int. Med. 2003, 14, 255.
8. Kumara, Y. R.; Raju, V. V. N. K. V. P.; Kumara, R. R.; Eswaraiah, S.; Mukkanti, K.; Suryanarayana, M. V.; Reddya, M. S.; J. Pharm. Biomed. Anal. 2004, 34, 1125.
9. Liu, P.; Stass, H.; Sullivan, J. T.; Ballow, C.; Lettieri, J.; Agarwal, V.; Clin. Ther. Wol. 1999, 2, 13.
10. Ba, B. B.; Etienne, R.; Ducint, D.; Quentin, C.; Saux, M. C.; J. Chromatogr., B : Anal. Technol. Biomed. Life Sci. 2001, 754, 107.
11. Kurata, M.; Kasuga, Y.; Nanba, E.; Nakamura, H.; Asano, T.; Haruta, K.; Inflamm. Res. 1995, 44, 461.
12. Deppermann, K. M.; Lode, H.; Drugs 1993, 45, 65.
13. Djurdjevic, P.; Ciric, A.; Djurdjevic, A.; Stankov, M.J.; J. Pharm. Biomed. Anal. 2009, 50, 117.
14. Gonzalez, J. A. O.; Mochon, M. C.; De La Rosa, F. J. B.; Microchim. Acta 2005, 151, 39.
15. Lemoine, T.; Breilh, D.; Ducint, D.; Dubrez, J.; Jougon, J.; Velly, J. F.; Saux, M. C.; J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2000, 742, 247.
16. Baietto, L.; D'Avolio, A.; De Rosa, F. G.; Garazzino, S.; Patanella, S.; Siccardi, M.; Sciandra, M.; Di Perri, G.; Ther. Drug Monit. 2009, 31, 104.
17. Nguyen, H. A.; Grellet, J.; Ba, B. B.; Quentin, C.; Saux, M. C.; J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2004, 810, 77.
18. Srinivas, N.; Narasu, L.; Shankar, B. P.; Mullangi, R.; Biomed. Chromatogr. 2008, 22, 1288.
19. Tatar, S.; J. Pharm. Biomed. Anal. 2007, 43, 320.
20. Nemutlu, E.; Kir, S.; Ozyuncu, O.; Beksac, M. S.; Chromatogr. 2007, 66, 15.
21. Ashiru, D. I. A.; Patel, R.; Basit, A. W.; J. Chromatogr., B : Anal. Technol. Biomed. Life Sci. 2007, 860, 235.
22. Lister, A. S.; Sci. Technol. 2005, 6, 191.
23. International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use; ICH Harmonized Tripartite Guideline, Validation of Analytical Procedure: Text and Methodology Q2 (R1) Complimentary Guideline on Methodology, Dated 06 Nov 1996, Incorporated in Nov 2005, London.
24. Linda, L. N.; Reviewer Guidance, Validation of Chromatographic Methods, Center for Drug Evaluation and Research (CDER), US Food and Drug Administration: Silver Spring, 1994.
25. Dong, M. W.; Modern HPLC for practicing scientists, John Wiley and Sons, 2006.
26. th ed., AOAC International: Gaithersburg, 2002, vol. 1.
27. th ed., United States Pharmacopeial Convention: Rockville, 2009.
28. Xiong, Y.; Xiao, K. P.; Rustum, A. M.; J. Pharm. Biomed. Anal. 2009, 49, 646.
29. Plackett, R. L.; Burman, J. P.; Biometrika 1943-1946, 33, 305.
30. Kenawi, I. M.; Barsoum B. N.; Youssef, M. A.; J. Pharm. Biomed Anal. 2005, 37, 655.
31. Sultana, N.; Arayne, M. S.; Naveed, S.; Shamshad, H.; Acta Chromatographica 2009, 21, 547.